SCHEMBL24919045

SCHEMBL24919045

c1ccc(C2(c3ccccc3)c3ccccc3-c3ccc(N(c4cccc(-c5cccc6ccccc56)c4)c4cccc(-c5cccc6ccccc56)c4)cc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.38
ACMSD Q8TDX5 1/20 0.38
CHRNA1 P02708 1/20 0.38
CHRNG P07510 1/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38
SLC6A2 P23975 1/20 0.38
CHRNB4 P30926 1/20 0.38
SLC6A4 P31645 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CHRND Q07001 1/20 0.38
KDM4E B2RXH2 3/20 0.34
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24919747 1.00 MCL1 (0.38) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL23224897 0.99 CHRNA1 (0.37) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL24918458 0.98 CHRNA1 (0.36) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL24919337 0.98 CHRNA1 (0.36) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL24919046 0.96 MCL1 (0.38) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL23224575 0.96 CHRNA1 (0.36) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL23224941 0.96 MCL1 (0.38) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL24918505 0.96 MCL1 (0.38) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL23239010 0.96 CHRNA1 (0.36) MCL1ACMSDCHRNA1CHRNGCHRNB1
SCHEMBL23239011 0.96 CHRNA1 (0.36) MCL1ACMSDCHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 MCL1 1725/4885ACMSD 1115/4885CHRNA1 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.